1266 related articles for article (PubMed ID: 20929341)
1. n-3 fatty acids and cardiovascular events after myocardial infarction.
Kromhout D; Giltay EJ; Geleijnse JM;
N Engl J Med; 2010 Nov; 363(21):2015-26. PubMed ID: 20929341
[TBL] [Abstract][Full Text] [Related]
2. No effect of n-3 fatty acids on high-sensitivity C-reactive protein after myocardial infarction: the Alpha Omega Trial.
Hoogeveen EK; Geleijnse JM; Kromhout D; Giltay EJ
Eur J Prev Cardiol; 2014 Nov; 21(11):1429-36. PubMed ID: 23774275
[TBL] [Abstract][Full Text] [Related]
3. Effect of Omega-3 Fatty Acid Supplementation on Plasma Fibroblast Growth Factor 23 Levels in Post-Myocardial Infarction Patients with Chronic Kidney Disease: The Alpha Omega Trial.
de Borst MH; Baia LC; Hoogeveen EK; Giltay EJ; Navis G; Bakker SJL; Geleijnse JM; Kromhout D; Soedamah-Muthu SS
Nutrients; 2017 Nov; 9(11):. PubMed ID: 29137111
[TBL] [Abstract][Full Text] [Related]
4. No effect of n-3 fatty acids supplementation on NT-proBNP after myocardial infarction: the Alpha Omega Trial.
Hoogeveen EK; Geleijnse JM; Kromhout D; van't Sant P; Gemen EF; Kusters R; Giltay EJ
Eur J Prev Cardiol; 2015 May; 22(5):648-55. PubMed ID: 24879357
[TBL] [Abstract][Full Text] [Related]
5. Effects of n-3 fatty acids on depressive symptoms and dispositional optimism after myocardial infarction.
Giltay EJ; Geleijnse JM; Kromhout D
Am J Clin Nutr; 2011 Dec; 94(6):1442-50. PubMed ID: 22030221
[TBL] [Abstract][Full Text] [Related]
6. n-3 fatty acids, ventricular arrhythmia-related events, and fatal myocardial infarction in postmyocardial infarction patients with diabetes.
Kromhout D; Geleijnse JM; de Goede J; Oude Griep LM; Mulder BJ; de Boer MJ; Deckers JW; Boersma E; Zock PL; Giltay EJ
Diabetes Care; 2011 Dec; 34(12):2515-20. PubMed ID: 22110169
[TBL] [Abstract][Full Text] [Related]
7. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.
Abdelhamid AS; Brown TJ; Brainard JS; Biswas P; Thorpe GC; Moore HJ; Deane KH; AlAbdulghafoor FK; Summerbell CD; Worthington HV; Song F; Hooper L
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD003177. PubMed ID: 30521670
[TBL] [Abstract][Full Text] [Related]
8. Effects of n-3 fatty acids on cognitive decline: a randomized, double-blind, placebo-controlled trial in stable myocardial infarction patients.
Geleijnse JM; Giltay EJ; Kromhout D
Alzheimers Dement; 2012 Jul; 8(4):278-87. PubMed ID: 21967845
[TBL] [Abstract][Full Text] [Related]
9. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.
Abdelhamid AS; Brown TJ; Brainard JS; Biswas P; Thorpe GC; Moore HJ; Deane KH; AlAbdulghafoor FK; Summerbell CD; Worthington HV; Song F; Hooper L
Cochrane Database Syst Rev; 2018 Jul; 7(7):CD003177. PubMed ID: 30019766
[TBL] [Abstract][Full Text] [Related]
10. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.
Abdelhamid AS; Brown TJ; Brainard JS; Biswas P; Thorpe GC; Moore HJ; Deane KH; Summerbell CD; Worthington HV; Song F; Hooper L
Cochrane Database Syst Rev; 2020 Feb; 3(3):CD003177. PubMed ID: 32114706
[TBL] [Abstract][Full Text] [Related]
11. n-3 Polyunsaturated fatty acids, fatal ischemic heart disease, and nonfatal myocardial infarction in older adults: the Cardiovascular Health Study.
Lemaitre RN; King IB; Mozaffarian D; Kuller LH; Tracy RP; Siscovick DS
Am J Clin Nutr; 2003 Feb; 77(2):319-25. PubMed ID: 12540389
[TBL] [Abstract][Full Text] [Related]
12. Effects of n-3 fatty acids on major cardiovascular events in statin users and non-users with a history of myocardial infarction.
Eussen SR; Geleijnse JM; Giltay EJ; Rompelberg CJ; Klungel OH; Kromhout D
Eur Heart J; 2012 Jul; 33(13):1582-8. PubMed ID: 22301766
[TBL] [Abstract][Full Text] [Related]
13. Effect of alpha linolenic acid supplementation on serum prostate specific antigen (PSA): results from the alpha omega trial.
Brouwer IA; Geleijnse JM; Klaasen VM; Smit LA; Giltay EJ; de Goede J; Heijboer AC; Kromhout D; Katan MB
PLoS One; 2013; 8(12):e81519. PubMed ID: 24349086
[TBL] [Abstract][Full Text] [Related]
14. Intake of n-3 fatty acids and long-term outcome in renal transplant recipients: a post hoc analysis of a prospective cohort study.
Pranger IG; Gruppen EG; van den Berg E; Soedamah-Muthu SS; Navis G; Gans RO; Muskiet FA; Kema IP; Joosten MM; Bakker SJ
Br J Nutr; 2016 Dec; 116(12):2066-2073. PubMed ID: 27993180
[TBL] [Abstract][Full Text] [Related]
15. Effect of omega-3 fatty acids on kidney function after myocardial infarction: the Alpha Omega Trial.
Hoogeveen EK; Geleijnse JM; Kromhout D; Stijnen T; Gemen EF; Kusters R; Giltay EJ
Clin J Am Soc Nephrol; 2014 Oct; 9(10):1676-83. PubMed ID: 25104273
[TBL] [Abstract][Full Text] [Related]
16. Eicosapentaenoic Acid Versus Docosahexaenoic Acid as Options for Vascular Risk Prevention: A Fish Story.
Singh S; Arora RR; Singh M; Khosla S
Am J Ther; 2016; 23(3):e905-10. PubMed ID: 25828517
[TBL] [Abstract][Full Text] [Related]
17. Effects of 1-year treatment with highly purified omega-3 fatty acids on depression after myocardial infarction: results from the OMEGA trial.
Zimmer R; Riemer T; Rauch B; Schneider S; Schiele R; Gohlke H; Diller F; Steinbeck G; Katus H; Senges J;
J Clin Psychiatry; 2013 Nov; 74(11):e1037-45. PubMed ID: 24330904
[TBL] [Abstract][Full Text] [Related]
18. Effects of the flavonol quercetin and α-linolenic acid on n-3 PUFA status in metabolically healthy men and women: a randomised, double-blinded, placebo-controlled, crossover trial.
Burak C; Wolffram S; Zur B; Langguth P; Fimmers R; Alteheld B; Stehle P; Egert S
Br J Nutr; 2017 Mar; 117(5):698-711. PubMed ID: 28366181
[TBL] [Abstract][Full Text] [Related]
19. Margarines fortified with α-linolenic acid, eicosapentaenoic acid, or docosahexaenoic acid alter the fatty acid composition of erythrocytes but do not affect the antioxidant status of healthy adults.
Egert S; Lindenmeier M; Harnack K; Krome K; Erbersdobler HF; Wahrburg U; Somoza V
J Nutr; 2012 Sep; 142(9):1638-44. PubMed ID: 22810989
[TBL] [Abstract][Full Text] [Related]
20. No effects of n-3 fatty acid supplementation on serum total testosterone levels in older men: the Alpha Omega Trial.
Giltay EJ; Geleijnse JM; Heijboer AC; de Goede J; Oude Griep LM; Blankenstein MA; Kromhout D
Int J Androl; 2012 Oct; 35(5):680-7. PubMed ID: 22394170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
